Biotech IP Review is an independent publication exploring the intersection of biotechnology, medical technology, and intellectual property.
The life sciences are advancing at an extraordinary pace—gene editing platforms, cell-based therapies, diagnostics, and materials-enabled medical devices are reshaping medicine and healthcare. At the same time, the intellectual property landscape governing these innovations is becoming more complex, technical, and strategically important.
Biotech IP Review exists to help navigate that complexity.
What We Do
Biotech IP Review analyzes:
- emerging biotechnology and medtech research
- published patent applications and issued patents
- foundational scientific literature shaping patentability
- trends in claim scope, enablement, and obviousness risk
The focus is not on legal advice, but on technical clarity—bridging scientific developments with how they appear, evolve, and are framed in the patent record.
Articles are written for:
- patent professionals
- scientists and engineers
- founders and technology strategists
- anyone interested in how life science innovation is protected and challenged
Our Perspective
Modern biotech and medtech patents sit at the crossroads of:
- molecular biology and genetics
- materials science and engineering
- data-driven and platform technologies
Understanding patent strategy in these fields requires fluency in both the science and the structure of patent disclosures. Biotech IP Review approaches topics with that dual lens—focusing on how ideas move from lab notebooks to claims, figures, and prosecution history.
About the Author
Biotech IP Review is authored by a U.S. Registered Patent Practitioner with a background in advanced materials, energy storage systems, and interdisciplinary technology development, and an active interest in life sciences and medical technologies.
The site reflects ongoing technical study, literature analysis, and engagement with published patent applications across biotechnology and medtech domains.
Disclaimer
Biotech IP Review is an independent, educational publication.
Content is provided for informational purposes only and does not constitute legal advice.
BioTech IP Review 